ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSUN Golden Sun Health Technology Group Ltd

6.41
-1.08 (-14.42%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Golden Sun Health Technology Group Ltd NASDAQ:GSUN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.08 -14.42% 6.41 6.40 7.50 7.44 6.33 7.31 53,196 01:00:00

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

28/09/2023 9:30pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2023

 

Commission File Number: 001-41425

 

Golden Sun Education Group Limited 

 

Profit Huiyin Square North Building,

Huashan 2018, Unit 1001,

Xuhui District, Shanghai, China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

 

 

Results of Golden Sun Education Group Limited’s 2023 Annual General Meeting

 

The 2023 annual general meeting of shareholders (the “Meeting”) of Golden Sun Education Group Limited (the “Company”) was held at 10:00 a.m. EST on September 26, 2023. In-person participants attended the Meeting at 8th Floor, Administration Building, 390 East Tiyuhui road, Hongkou District, Shanghai, China, and remote participants attended the Meeting at www.virtualshareholdermeeting.com/GSUN2023, pursuant to notice duly given. Capitalized terms not otherwise defined herein shall have the meanings given to them in the Company’s current amended and restated memorandum and articles of association.

 

At the close of business on August 7, 2023, the record date for the determination of shareholders entitled to vote at the Meeting, there were 14,325,491 Class A ordinary shares outstanding, each share being entitled to one (1) vote; and 4,030,000 Class B ordinary shares outstanding, each share being entitled to five (5) votes; constituting all of the 19,085,491 shares of outstanding voting securities of the Company and representing 35,205,491 outstanding votes. At the Meeting, the holders of 8,503,961 shares of outstanding voting securities of the Company were represented in person or by proxy, constituting a quorum and representing 24,623,961 votes of voting power,

 

The shareholders of the Company adopted ordinary resolutions that:

 

No 1. to re-elect Mr. Xueyuan Weng as a director of the Company to hold office until the next annual general meeting;

 

No 2. to re-elect Ms. Peilin Ji as a director of the Company to hold office until the next annual general meeting;

 

No 3. to re-elect Mr. Liming Xu as a director of the Company to hold office until the next annual general meeting;

 

No 4. to re-elect Mr. Robert Travers as a director of the Company to hold office until the next annual general meeting;

 

No 5. to re-elect Mr. Wenlong Xia as a director of the Company to hold office until the next annual general meeting;

 

No 6. to re-elect Mr. Yidong Hao as a director of the Company to hold office until the next annual general meeting;

 

No 7. to elect Mr. Zhenghua Yu as a director of the Company to hold office until the next annual general meeting.

 

The shareholders of the Company adopted special resolutions that:

 

No 8. to change the Company’s name to “Golden Sun Health Technology Group Limited” and the Chinese translation of the Company’s name to “金太阳健康科技集团有限公司”;

 

No 9. to adopt a third amended and restated memorandum and articles of association in the form set out in Annex A to the accompanying proxy statement in substitution for, and to the exclusion of, the current amended and restated memorandum and articles of association of the Company.

 

The results of the votes for the resolutions were as follows:

 

Resolution  For   Against   Abstain 
No.1   24,543,234    25,462    55,265 
No.2   25,541,874    24,822    57,265 
No.3   24,540,336    26,360    57,265 
No.4   24,542,890    23,806    57,265 
No.5   24,541,345    25,351    57,265 
No.6   24,540,251    26,445    57,265 
No.7   24,539,678    26,343    57,940 
No.8   24,597,529    24,100    2,332 
No.9   24,599,088    23,861    1,012 

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Golden Sun Education Group Limited
     
Date: September 28, 2023 By: /s/ Xueyuan Weng
  Name: Xueyuan Weng
  Title: Chief Executive Officer

 

 

2

 


1 Year Golden Sun Health Techno... Chart

1 Year Golden Sun Health Techno... Chart

1 Month Golden Sun Health Techno... Chart

1 Month Golden Sun Health Techno... Chart

Your Recent History

Delayed Upgrade Clock